Possible approach discovered for treating Multiple SclerosisAround 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the most common central nervous system disease among young adults. There are around 12,500 MS...
Research to Tackle MS Symptoms and Progression Among Reports from the American Academy of Neurology/About-the-Society/News/Research-to-Tackle-MS-Symptoms-Among-Reports-from … read morePosted At: National MS Society
Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI
Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRIMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
MS Researchers Review Advances in Understanding Progressive MS and Highlight Urgency for Answers/About-the-Society/News/MS-Researchers-Review-Advances-in-Understanding-Pr … read morePosted At: National MS Society
Early Clinical Trial Results and Observational Study Support Further Research of “Probiotic” Parasit
Early Clinical Trial Results and Observational Study Support Further Research of “Probiotic” Parasit/About-the-Society/News/Early-Clinical-Trial-Results-and-Observational-Stu … read morePosted At: National MS Society
Join Our Mailing List
- Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome
- False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin
- What to know about marijuana and multiple sclerosis
- Using graphene to detect ALS, other neurodegenerative diseasesPosted At: Science Daily
- Is the ketogenic diet good for multiple sclerosis?
- What is Lhermitte’s sign?
- What to know about multiple sclerosis and mood swings
- FDA Issues Warning About Rare Risk of Stroke and Artery Wall Tears with Use of Lemtrada Posted At: National MS Society
- Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria
- Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium